Hemochromatosis: course and treatment.
D000328:Adult; D000740:Anemia / Q000378:metabolism; D001815:Bloodletting; D006528:Carcinoma, Hepatocellular / Q000150:complications; D048909:Diabetes Complications; D005260:Female; D006323:Heart Arrest / Q000150:complications; D006432:Hemochromatosis / Q000150:complications / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use; D007501:Iron / Q000378:metabolism; D007502:Iron Chelating Agents / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000150:complications / Q000378:metabolism; D008113:Liver Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D011166:Porphyrins / Q000378:metabolism; D011167:Portacaval Shunt, Surgical; D011379:Prognosis; D013733:Testicular Diseases / Q000150:complications
D006877:Hydroxamic Acids; D007502:Iron Chelating Agents; D011166:Porphyrins; D007501:Iron